Model parameters and baseline values
Parameter | Symbol | Baseline value | Source |
Probability of developing de novo resistance on therapy | rA, rB | 0.000001 | Assumption |
Natural recovery rate (1/year) | v | 8.67 | Best estimate* |
High risk | Intermediate risk | Low risk | |||
Population size | Ni | 2308 | 23 077 | 974 615 | |
Proportion of population | 0.0023 | 0.023 | 0.97 | ||
Total annual partnerships | ci | 9.27 | 1.62 | 0.056 | Equation (6) |
Proportion of sexual partnerships | |||||
High risk | p3i | 0.931 | 0.0669 | 0.002 | |
Intermediate risk | p2i | 0.4926 | 0.4926 | 0.0148 | |
Low risk | p1i | 0.33 | 0.33 | 0.33 | |
Baseline daily rate of treatment using drug A and/or B | tAi, tBi, tABi | ||||
Single-drug treatment | tAi | 0.003 | 0.003 | 0.003 |
↵* Based on descriptions in available medical literature on duration of NG infections lasting from weeks to months when untreated.11 30